Erector Spinae Plane Block in Renal Transplantation Donors
NCT ID: NCT04863716
Last Updated: 2022-09-22
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
52 participants
INTERVENTIONAL
2021-04-28
2022-04-14
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The aim of the study is to provide analgesia to donor patients using less opioids by Erector Spina Plan Block and provide enhanced recovery.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Erector Spinae Plane Block in Liver Transplantation Donors
NCT05406388
Effectivenes of Erector Spinae Plane Block in Percutaneous Nephrolithotomy?
NCT04474873
Clinical Effectiveness of Erector Spinae Plane Block in Peri-operative Analgesia for Nephrectomy/Nephron Sparing Surgery(NSS) Performed Via Lumbotomy
NCT03887260
Effect of ESPB on Intraoperative Remifentanil Consumption
NCT06303557
Transversalis Fascia Plane Block and Rectus Sheath Block in Renal Transplantation Donors
NCT05324215
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Erector Spinae Plane Block
Erector Spinae Plane Block will be administered to this group.
Erector Spinae Plane Block
Erector Spinae Plane Block will be administered before the surgery.
Intravenous fentanyl patient control device
24-hour fentanyl consumption will be recorded.
Control Group
No regional anesthesia technique will be applied to the control group.
Intravenous fentanyl patient control device
24-hour fentanyl consumption will be recorded.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Erector Spinae Plane Block
Erector Spinae Plane Block will be administered before the surgery.
Intravenous fentanyl patient control device
24-hour fentanyl consumption will be recorded.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* ASA I-II
* Patients who are aged between 18-75
Exclusion Criteria
* Coagulation disorder or using anticoagulant drugs
* End-stage organ and system failure
* Severe pulmonary and/or cardiovascular problems
* Substance addiction or known psychiatric or mental problems
* Chronic painkiller usage
18 Years
75 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Koc University Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Özlem Özkalaycı
Anesthesiologist
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Koç University Hospital
Istanbul, Zeytinburnu, Turkey (Türkiye)
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
KocUniversityH
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.